| Title |
Tissue-based markers as a tool to assess response to neoadjuvant radiotherapy in rectal cancer-systematic review / |
| Authors |
Smolskas, Edgaras ; Mikulskytė, Goda ; Šileika, Ernestas ; Sužiedėlis, Kęstutis ; Dulskas, Audrius |
| DOI |
10.3390/ijms23116040 |
| Full Text |
|
| Is Part of |
International journal of molecular sciences.. Basel : MDPI. 2022, vol. 23, iss. 11, art. no. 6040, p. 101-174.. ISSN 1661-6596. eISSN 1422-0067 |
| Keywords [eng] |
rectal cancer ; neoadjuvant chemoradiotherapy ; radiosensitivity markers ; micro-RNA ; tumor immune microenvironment |
| Abstract [eng] |
According to current guidelines, the current treatment for locally advanced rectal cancer is neoadjuvant therapy, followed by a total mesorectal excision. However, radiosensitivity tends to differ among patients due to tumor heterogeneity, making it difficult to predict the possible outcomes of the neoadjuvant therapy. This review aims to investigate different types of tissue-based biomarkers and their capability of predicting tumor response to neoadjuvant therapy in patients with locally advanced rectal cancer. We identified 169 abstracts in NCBI PubMed, selected 48 re-ports considered to meet inclusion criteria and performed this systematic review. Multiple classes of molecular biomarkers, such as proteins, DNA, micro-RNA or tumor immune microenvironment, were studied as potential predictors for rectal cancer response; nonetheless, no literature to date has provided enough sufficient evidence for any of them to be introduced into clinical practice. |
| Published |
Basel : MDPI |
| Type |
Journal article |
| Language |
English |
| Publication date |
2022 |
| CC license |
|
